Impax Asset Management Group’s Stericycle Inc SRCL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-1,406,625
Closed -$85.2M 338
2024
Q3
$85.2M Sell
1,406,625
-1,518,516
-52% -$90.1M 0.34% 75
2024
Q2
$169M Sell
2,925,141
-200,253
-6% -$10.3M 0.69% 54
2024
Q1
$164M Sell
3,125,394
-13,638
-0.4% -$686K 0.63% 56
2023
Q4
$154M Buy
3,139,032
+147,452
+5% +$6.62M 0.62% 58
2023
Q3
$133M Buy
2,991,580
+66,746
+2% +$2.98M 0.59% 57
2023
Q2
$135M Sell
2,924,834
-18,948
-0.6% -$829K 0.54% 64
2023
Q1
$127M Buy
2,943,782
+29,184
+1% +$1.44M 0.53% 63
2022
Q4
$144M Buy
2,914,598
+117,624
+4% +$5.6M 0.65% 55
2022
Q3
$117M Buy
2,796,974
+528,468
+23% +$25.4M 0.6% 62
2022
Q2
$98.8M Sell
2,268,506
-9,775
-0.4% -$484K 0.48% 70
2022
Q1
$133M Buy
2,278,281
+66,647
+3% +$3.86M 0.55% 65
2021
Q4
$131M Buy
2,211,634
+589,128
+36% +$36.9M 0.48% 71
2021
Q3
$109M Buy
1,622,506
+395,632
+32% +$27.3M 0.45% 69
2021
Q2
$87M Buy
+1,226,874
New +$90.2M 0.38% 71

Other funds holding SRCL

Impax Asset Management Group's SRCL Position: Q4 2024 in Review

Impax Asset Management Group sold out of Stericycle Inc (SRCL) in Q4 2024, closing a stake of 1,406,625 shares — an estimated $85.2M sold.

Impax Asset Management Group first reported a position in SRCL in Q2 2021 and held it in 14 quarters. The position peaked at $169M in Q2 2024. 4 funds tracked by Wall St. Rank hold SRCL as of Q4 2024.

  • Impax Asset Management Group reported no remaining Stericycle Inc position as of Q4 2024 after selling out during the quarter.
  • Impax Asset Management Group sold 1,406,625 Stericycle Inc shares in Q4 2024, an estimated $85.2M.
  • Impax Asset Management Group first reported a position in Stericycle Inc in Q2 2021 and held it in 14 quarters.
  • Impax Asset Management Group's Stericycle Inc position peaked at $169M in Q2 2024.
  • 4 funds tracked by Wall St. Rank held Stericycle Inc as of Q4 2024.

Based on Impax Asset Management Group's 13F filing for Q4 2024, filed 4 Feb 2025.